Leo scores again in hand eczema with its JAK inhibitor cream
Fierce Pharma
JANUARY 24, 2024
It’s been four years since Japan Tobacco snagged approval in its home country for its topical JAK inhibitor delgoci | It’s been four years since Japan Tobacco snagged approval in its home country for its topical JAK inhibitor delgocitinib to treat atopic dermatitis.
Let's personalize your content